Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Multi-Institutional, Phase II Open-Label Study of AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01024387
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:59.264849+00:00
Published At
2017-12-27T00:00:00+00:00
Record Updated At
2018-03-08
Results Posted At
2017-12-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Neuroendocrine Tumor", "Carcinoid Tumor", "Pancreatic Neuroendocrine Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-03-08"
protocolSection.identificationModule.nctId
"NCT01024387"
protocolSection.identificationModule.officialTitle
"A Multi-Institutional, Phase II Open-Label Study of AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-12-27"

Study condition terms

  • Neuroendocrine Tumor (protocolSection.conditionsModule.conditions)
  • Carcinoid Tumor (protocolSection.conditionsModule.conditions)
  • Pancreatic Neuroendocrine Tumor (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.